EGRI and FOSB gene expressions in cancer stroma are independent prognostic indicators for epithelial ovarian cancer receiving standard therapy

Genes Chromosomes and Cancer

Volumn 51, Issue 3, 2012, Pages 300-312

  Kataoka, Fumio ^a   Tsuda, Hiroshi ^a   Arao, Tokuzo ^b   Nishimura, Sadako ^c   Tanaka, Hideo ^a   Nomura, Hiroyuki ^a   Chiyoda, Tatsuyuki ^a   Hirasawa, Akira ^a   Akahane, Tomoko ^a   Nishio, Hiroshi ^a   Nishio, Kazuto ^b   Aoki, Daisuke ^a  

^a KEIO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA CITY GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; COMPLEMENTARY DNA; PACLITAXEL; RNA;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; EARLY GROWTH RESPONSE 1 GENE; EPITHELIAL OVARIAN CANCER; FBJ MURINE OSTEOSARCOMA VIRAL ONCOGENE HOMOLOG B GENE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MULTIVARIATE ANALYSIS; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOFIBROBLASTS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-FOS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL;

MURINAE;

EID: 84855505679     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.21916     Document Type: Article

References (27)

1. Adamson E, de Belle I, Mittal S, Wang Y, Hayakawa J, Korkmaz K, O'Hagan D, McClelland M, Mercola D. 2003. Egr1 signaling in prostate cancer. Cancer Biol Ther 2: 617-622.
2. Barbolina MV, Adley BP, Ariztia EV, Liu Y, Stack MS. 2007. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced egr1 expression. J Biol Chem 282: 4924-4931.
3. Bhowmick NA, Moses HL. 2005. Tumor-stroma interactions. Curr Opin Genet Dev 15: 97-101.
4. Dakhova O, Ozen M, Creighton CJ, Li R, Ayala G, Rowley D, Ittmann M. 2009. Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res 15: 3979-3989.
5. Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM. 2003. Transcription factor egr-1 supports fgf-dependent angiogenesis during neovascularization and tumor growth. Nat Med 9: 1026-1032.
6. Ferraro B, Bepler G, Sharma S, Cantor A, Haura EB. 2005. Egr1 predicts pten and survival in patients with non-small-cell lung cancer. J Clin Oncol 23: 1921-1926.
7. Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M. 2008. Stromal gene expression predicts clinical outcome in breast cancer. Nat Med 14: 518-527.
8. Gregg JL, Brown KE, Mintz EM, Piontkivska H, Fraizer GC. 2010. Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection. BMC cancer 10: 165.
9. Hirasawa A, Saito-Ohara F, Inoue J, Aoki D, Susumu N, Yokoyama T, Nozawa S, Inazawa J, Imoto I. 2003. Association of 17q21-q24 gain in ovarian clear cell adenocarcinomas with poor prognosis and identification of ppm1d and appbp2 as likely amplification targets. Clin Cancer Res 9: 1995-2004.
10. Kalluri R, Zeisberg M. 2006. Fibroblasts in cancer. Nat Rev Cancer 6: 392-401.
11. Kato K, Takao T, Kuboyama A, Tanaka Y, Ohgami T, Yamaguchi S, Adachi S, Yoneda T, Ueoka Y, Hayashi S, Asanoma K, Wake N. 2010. Endometrial cancer side-population cells show prominent migration and have a potential to differentiate into the mesenchymal cell lineage. Am J Pathol 176: 381-392.
12. Khachigian LM, Lindner V, Williams AJ, Collins T. 1996. Egr-1-induced endothelial gene expression: A common theme in vascular injury. Science 271: 1427-1431.
13. Kim JB, Stein R, O'Hare MJ. 2005. Tumour-stromal interactions in breast cancer: The role of stroma in tumourigenesis. Tumour Biol 26: 173-185.
14. Kobayashi D, Yamada M, Kamagata C, Kaneko R, Tsuji N, Nakamura M, Yagihashi A, Watanabe N. 2002. Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res 22: 3963-3970.
15. Maegawa M, Arao T, Yokote H, Matsumoto K, Kudo K, Tanaka K, Kaneda H, Fujita Y, Ito F, Nishio K. 2009. Egfr mutation up-regulates egr1 expression through the erk pathway. Anticancer Res 29: 1111-1117.
16. Milde-Langosch K, Roder H, Andritzky B, Aslan B, Hemminger G, Brinkmann A, Bamberger CM, Loning T, Bamberger AM. 2004. The role of the ap-1 transcription factors c-fos, fosb, fra-1 and fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res Treat 86: 139-152.
17. Naora H, Montell DJ. 2005. Ovarian cancer metastasis: Integrating insights from disparate model organisms. Nat Rev Cancer 5: 355-366.
18. Nishi H, Nishi KH, Johnson AC. 2002. Early growth response-1 gene mediates up-regulation of epidermal growth factor receptor expression during hypoxia. Cancer Res 2002; 62: 827-834.
19. Saegusa M, Hashimura M, Kuwata T, Hamano M, Watanabe J, Kawaguchi M, Okayasu I. 2008. Transcription factor egr1 acts as an upstream regulator of beta-catenin signalling through up-regulation of tcf4 and p300 expression during trans-differentiation of endometrial carcinoma cells. J Pathol 216: 521-532.
20. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J, Vivas-Mejia P, Lutgendorf SK, Lopez-Berestein G, Bar-Eli M, Cole SW, Sood AK. 2010. Stress effects on fosb- and interleukin-8 (il8)-driven ovarian cancer growth and metastasis. J Biol Chem 285: 35462-35470.
21. Sperandio S, Fortin J, Sasik R, Robitaille L, Corbeil J, de Belle I. 2009. The transcription factor egr1 regulates the hif-1alpha gene during hypoxia. Mol Carcinog 48: 38-44.
22. Tlsty TD, Coussens LM. 2006. Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
23. Tominaga E, Tsuda H, Arao T, Nishimura S, Takano M, Kataoka F, Nomura H, Hirasawa A, Aoki D, Nishio K. 2010. Amplification of gnas may be an independent, qualitative, and reproducible biomarker to predict progression-free survival in epithelial ovarian cancer. Gynecol Oncol 118: 160-166.
24. Tsuda H, Birrer MJ, Ito YM, Ohashi Y, Lin M, Lee C, Wong WH, Rao PH, Lau CC, Berkowitz RS, Wong KK, Mok SC. 2004. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cdna microarray platform. Cancer Genet Cytogenet 155: 97-107.
25. Tsuda H, Ito YM, Ohashi Y, Wong KK, Hashiguchi Y, Welch WR, Berkowitz RS, Birrer MJ, Mok SC. 2005. Identification of overexpression and amplification of abcf2 in clear cell ovarian adenocarcinomas by cdna microarray analyses. Clin Cancer Res 11: 6880-6888.
26. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. 2003. Egr1 promotes growth and survival of prostate cancer cells. Identification of novel egr1 target genes. J Biol Chem 278: 11802-11810.
27. Wu MY, Zhuang CX, Yang HX, Liang YR. 2004. Expression of egr-1, c-fos and cyclin d1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J Gastroenterol 10: 476-480.